Modulation of phenotypic expression of APOA5 Q97X and L242P mutations

Area of Science:

• Human Genetics
• Molecular Biology
• Biochemistry

Background:

• Apolipoprotein A5 (APOA5) plays a critical role in triglyceride metabolism.
• Mutations in APOA5 are a known cause of severe hypertriglyceridemia.
• Understanding genotype-phenotype correlations is crucial for managing dyslipidemias.

Observation:

• Sequencing of the APOA5 gene in 286 hyperchylomicronemic subjects identified carriers of the Q97X mutation and a novel L242P mutation.
• Q97X heterozygotes showed a ~50% reduction in LPL activity, while homozygotes had >90% reduction and undetectable apoAV.
• The L242P mutation's role was unclear, but Q97X carriers exhibited altered apoAV-lipoprotein association.

Findings:

• The Q97X mutation is clearly implicated in hyperchylomicronemia, causing altered lipolysis and apoAV deficiency in homozygotes.
• Phenotypic variability of APOA5 mutations is primarily driven by compound heterozygosity and additional genetic factors.
• Metabolic factors like diabetes and metabolic syndrome had a lesser influence on phenotypic expression.

Implications:

• These findings deepen our understanding of APOA5's role in lipid metabolism and the genetic basis of hypertriglyceridemia.
• Identification of novel mutations and their functional consequences aids in diagnosing and potentially treating genetic dyslipidemias.
• The study highlights the complex interplay of genetic factors in determining the severity of APOA5-related hyperchylomicronemia.